Form 4 holding
Chief Commercial Officer
Compass Therapeutics, Inc.
- Security class
- STOCK OPTION (RIGHT TO BUY)
- Shares / value
- 1,000,000
- Estimated value
- Report date
- 02 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- COMMON STOCK
- Underlying amount